Advertisement

Ads Placeholder
Loading...

Xuanzhubio-b

2575.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$31.06
HK$0.82(2.71%)
Hong Kong Market opens in 10h 28m

Xuanzhubio-b (2575.HK) Stock Overview

Explore Xuanzhubio-b’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap16.1B
P/E Ratio-26.67
EPS (TTM)$-0.60
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 Month$69.63
3 Months$80.31
1 Year Target$135.76

2575.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Xuanzhubio-b (2575.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 27.36, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $135.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -26.67 and a market capitalization of 16.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.71%
5-Day Change
-14.01%
1-Month Change
-49.08%
3-Month Change
-52.36%
6-Month Change
18.10%
Year-to-Date (YTD) Change
-52.36%
1-Year Change
18.10%
3-Year Change
18.10%
5-Year Change
18.10%
All-Time (Max) Change
18.10%

Contact Information

https://www.xuanzhubio.com
NaN
2107, Building 2, Beijing, NaN, NaN

Company Facts

1,970 Employees
IPO DateOct 15, 2025
CountryCN
Actively Trading

Frequently Asked Questions